13D/13G Filings - Vivo Capital IX, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
08:34 am
Unchanged
2025-03-3113GSera Prognostics, Inc.
SERA
Vivo Capital IX, LLC1,650,440
4.500%
0
(Unchanged)
Filing
History
2025-03-19
3:00 pm
Purchase
2025-03-1713DSINOVAC BIOTECH LTD
SVA
Vivo Capital IX, LLC4,539,456
6.300%
4,539,456increase
(New Position)
Filing
History
2024-11-14
6:59 pm
Purchase
2024-09-3013GInstil Bio, Inc.
TIL
Vivo Capital IX, LLC585,485
9.000%
585,485increase
(New Position)
Filing
History
2024-04-02
5:44 pm
Unchanged
2024-03-2813DGenetron Holdings Limited
GTH
Vivo Capital IX, LLC0
0.000%
0
(Unchanged)
Filing
History
2024-02-13
5:03 pm
Sale
2023-12-3113GTarsus Pharmaceuticals, Inc.
TARS
Vivo Capital IX, LLC894,826
2.700%
-1,367,374decrease
(-60.44%)
Filing
History
2024-02-13
5:00 pm
Sale
2023-12-3113GSera Prognostics, Inc.
SERA
Vivo Capital IX, LLC1,650,440
5.400%
-205,571decrease
(-11.08%)
Filing
History
2023-10-19
4:30 pm
Purchase
2023-10-1113DGenetron Holdings Limited
GTH
Vivo Capital IX, LLC9,524,767
6.000%
9,524,767increase
(New Position)
Filing
History
2023-02-13
5:54 pm
Sale
2022-12-3113GIVERIC bio, Inc.
ISEE
Vivo Capital IX, LLC0
0.000%
-5,202,348decrease
(Position Closed)
Filing
History
2023-02-13
5:52 pm
Sale
2022-12-3113GTarsus Pharmaceuticals, Inc.
TARS
Vivo Capital IX, LLC2,262,200
8.500%
-725,131decrease
(-24.27%)
Filing
History
2023-02-13
5:51 pm
Purchase
2022-12-3113GGenetron Holdings Limited
GTH
Vivo Capital IX, LLC9,524,767
6.300%
9,524,767increase
(New Position)
Filing
History
2023-02-13
5:48 pm
Sale
2022-12-3113GMereo BioPharma Group plc
MREO
Vivo Capital IX, LLC3,761,947
3.100%
-5,647,104decrease
(-60.02%)
Filing
History
2023-02-13
5:44 pm
Purchase
2022-12-3113GKalVista Pharmaceuticals, Inc.
KALV
Vivo Capital IX, LLC772,068
2.300%
772,068increase
(New Position)
Filing
History
2022-07-05
5:06 pm
Sale
2022-07-0113GSierra Oncology, Inc.
SRRA
Vivo Capital IX, LLC0
0.000%
-1,935,853decrease
(Position Closed)
Filing
History
2022-02-11
5:27 pm
Sale
2021-12-3113GLarimar Therapeutics, Inc.
LRMR
Vivo Capital IX, LLC326,888
1.800%
-326,891decrease
(-50.00%)
Filing
History
2022-02-11
5:26 pm
Purchase
2021-12-3113GMereo BioPharma Group plc
MREO
Vivo Capital IX, LLC9,409,051
7.800%
448,755increase
(+5.01%)
Filing
History
2022-02-11
5:25 pm
Purchase
2021-12-3113GIVERIC bio, Inc.
ISEE
Vivo Capital IX, LLC5,202,348
4.500%
5,202,348increase
(New Position)
Filing
History
2022-02-11
5:23 pm
Purchase
2021-12-3113GESSA Pharma Inc.
EPIX
Vivo Capital IX, LLC624,902
1.400%
624,902increase
(New Position)
Filing
History
2022-02-11
5:22 pm
Purchase
2022-01-3113GSierra Oncology, Inc.
SRRA
Vivo Capital IX, LLC2,735,852
14.700%
2,735,852increase
(New Position)
Filing
History
2022-02-11
5:21 pm
Sale
2021-12-3113GTarsus Pharmaceuticals, Inc.
TARS
Vivo Capital IX, LLC2,987,331
14.400%
-257,704decrease
(-7.94%)
Filing
History
2021-11-12
4:30 pm
Purchase
2021-11-0913GIO Biotech, Inc.
IOBT
Vivo Capital IX, LLC3,015,545
10.500%
3,015,545increase
(New Position)
Filing
History
Goto 0, 1, Next